Parents and physicians reporting a primary goal of cure/life extension
| . | SCT, % (n = 31) . | Non-SCT, % (n = 110) . | RD, % (95% CI) . | P* . |
|---|---|---|---|---|
| Parents | ||||
| For last cancer therapy | 20/26 (77) | 39/87 (45) | 32 (10, 54) | .007 |
| During EOL period† | 15/31 (48) | 22/109 (20) | 28 (7, 49) | .003 |
| At time of death | 9/29 (31) | 5/103 (5) | 26 (7, 46) | < .001 |
| Physicians | ||||
| In last month of life | 24/29 (83) | 39/103 (38) | 44 (26, 64) | < .001 |
| At time of death | 6/28 (21) | 6/106 (5) | 16 (−2, 34) | .02 |
| . | SCT, % (n = 31) . | Non-SCT, % (n = 110) . | RD, % (95% CI) . | P* . |
|---|---|---|---|---|
| Parents | ||||
| For last cancer therapy | 20/26 (77) | 39/87 (45) | 32 (10, 54) | .007 |
| During EOL period† | 15/31 (48) | 22/109 (20) | 28 (7, 49) | .003 |
| At time of death | 9/29 (31) | 5/103 (5) | 26 (7, 46) | < .001 |
| Physicians | ||||
| In last month of life | 24/29 (83) | 39/103 (38) | 44 (26, 64) | < .001 |
| At time of death | 6/28 (21) | 6/106 (5) | 16 (−2, 34) | .02 |
Crude (unadjusted) proportions and risk differences are presented. Denominators are based on number of respondents for each item and may differ from total sample size.
SCT indicates stem cell transplantation; RD, risk difference; CI, confidence interval; and EOL, end-of-life.
Unadjusted P values are presented. P values remained significant after adjustment for time since death.
The EOL period is defined as the period of time during which the parent understood that their child had no realistic chance for cure.